These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6245007)

  • 1. Factors affecting E-rosette forming ability in peripheral lymphocytes of insulin dependent diabetics.
    Cattaneo R; Saibene V; Pescatori D; Mersi A; Pozza G
    Diabetologia; 1980; 18(2):115-9. PubMed ID: 6245007
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subpopulations of peripheral lymphocytes in insulin-dependent diabetics (author's transl)].
    Nagaoka K; Nabeya N; Sakurami T; Imura H; Kuno S
    Nihon Naibunpi Gakkai Zasshi; 1978 Jan; 54(1):36-42. PubMed ID: 305369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leucocyte migration inhibition test and subpopulations of peripheral lymphocytes in insulin-dependent diabetics.
    Nagaoka K; Sakurami T; Nabeya N; Imura H; Kuno S
    Endocrinol Jpn; 1979 Feb; 26(1):89-95. PubMed ID: 312198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity in diabetes mellitus by phytohaemagglutinin transformation and sheep erythrocyte rosette test.
    Mohan H; Yadav MS; Singh U; Ichhpujani RL
    Indian J Pathol Microbiol; 1983 Jul; 26(3):185-91. PubMed ID: 6668022
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of insulin treatment on the metabolic response to glucagon in diabetes.
    Elkeles RS; Hambley J; Frost PG
    Diabete Metab; 1977 Mar; 3(1):35-8. PubMed ID: 192610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Demonstration of anti-pancreatic cellular immunity in insulin-dependent diabetics].
    Debray-Sachs M; Boitard C; Assan R; Pouplard A
    C R Seances Soc Biol Fil; 1980; 174(4):517-26. PubMed ID: 6449237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of halothane on E, EA, and EAC rosette formation and cyclic AMP level of human lymphocytes.
    Ryhänen P; Karppanen H; Yrjänheikki E; Hollmén A
    Med Biol; 1978 Jun; 56(3):144-7. PubMed ID: 210335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effect of insulin on peripheral T-lymphocyte E-rosette function from normal and diabetic subjects.
    Cattaneo R; Saibene V; Margonato A; Pozza G
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):139-43. PubMed ID: 326272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of human lymphocyte subpopulations to pharmacologic stimulation. I. Lymphocyte responsiveness to beta adrenergic agents.
    Galant SP; Underwood SB; Lundak TC; Groncy CC; Mouratides DI
    J Allergy Clin Immunol; 1978 Dec; 62(6):349-56. PubMed ID: 213463
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.
    Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
    J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity in diabetes mellitus; lymphocyte transformation by insulin and insulin fragments in insulin-treated and newly-diagnosed diabetes.
    MacCuish AC; Jordan J; Campbell CJ; Duncan LJ; Irvine WJ
    Diabetes; 1975 Jan; 24(1):36-43. PubMed ID: 1120544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of allogeneic lymphocyte E-rosettes induced by sera from newly diagnosed type I diabetics.
    Pozzilli P; Di Mario U; Javicoli M; Menzinger G; Andreani D
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):49-53. PubMed ID: 6986737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive insulin and C-peptide responses to various insulin secretory stimuli in subjects with type 2 diabetes and in control subjects during continuous glucose monitoring.
    Ahrén B; Scherstén B; Agardh CD; Lundquist I
    Acta Med Scand; 1981; 210(5):337-48. PubMed ID: 7039239
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics.
    Gerich JE; Lorenzi M; Schneider V; Kwan CW; Karam JH; Guillemin R; Forsham PH
    Diabetes; 1974 Nov; 23(11):876-80. PubMed ID: 4430415
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclic nucleotides in diabetes mellitus and obesity.
    Exton JH
    Adv Cyclic Nucleotide Res; 1980; 12():319-27. PubMed ID: 6250364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glucagon antibodies in the blood of insulin-treated diabetics (effect of monospecific and monocomponent insulin therapy on antibody level)].
    Korányi L; Tamás G; Gerö L; Halmos T; Baranyai E; Büki B
    Orv Hetil; 1981 Jun; 122(23):1371-4. PubMed ID: 7024892
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of diabetes mellitus and insulin on the turnover and metabolic response to ketones in man.
    Sherwin RS; Hendler RG; Felig P
    Diabetes; 1976 Sep; 25(9):776-84. PubMed ID: 955305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlations between NEFA and ketone bodies in normal and diabetic subjects].
    Odetti P; Diara C; Corsi L; Viviani G; Maiello M; Cordera R; De Micheli A; Prando R
    Boll Soc Ital Biol Sper; 1980 Jan; 56(2):146-52. PubMed ID: 7002170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of the mitogenic and rosette-forming effects of PHA to stimulators of cyclic AMP levels.
    Kalmár L; Gergely P; Petrányi G
    Acta Med Acad Sci Hung; 1978; 35(2):147-51. PubMed ID: 217221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.